Literature DB >> 1451953

Reproducibility of glycaemic thresholds for activation of counterregulatory hormones and hypoglycaemic symptoms in healthy subjects.

H Vea1, R Jorde, G Sager, S Vaaler, J Sundsfjord.   

Abstract

Nine healthy subjects were studied on two separate occasions, at least two weeks apart, using the glucose clamp technique to produce a gradual hypoglycaemia. Glucose thresholds for neuroendocrine and symptom responses varied up to 1.5 mmol/l between subjects. There was a significant correlation between individual glucose thresholds on day 1 and 2 for adrenaline (p = 0.0008), growth hormone (p = 0.007) and pancreatic polypeptide (p = 0.02), and for autonomic (p = 0.018) and neuroglycopoenic (p = 0.023) symptoms, whereas no significant correlations were found for glucagon and cortisol. The mean intra-individual differences in glucose thresholds between day 1 and 2 were 0.22 mmol/l for the hormones and 0.25 mmol/l for the symptoms. We conclude that healthy subjects differ in hypoglycaemic thresholds, and that the difference reflects individual variation.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1451953     DOI: 10.1007/bf00401425

Source DB:  PubMed          Journal:  Diabetologia        ISSN: 0012-186X            Impact factor:   10.122


  13 in total

1.  Glycaemic thresholds for hypoglycaemic symptoms, impairment of cognitive function, and release of counterregulatory hormones in subjects with functional hypoglycaemia.

Authors:  O Snorgaard; L H Lassen; A M Rosenfalck; C Binder
Journal:  J Intern Med       Date:  1991-04       Impact factor: 8.989

2.  Deficient counterregulatory hormone responses during hypoglycemia in a patient with insulinoma.

Authors:  M R Davis; H Shamoon
Journal:  J Clin Endocrinol Metab       Date:  1991-04       Impact factor: 5.958

3.  Rate of glucose fall does not affect counterregulatory hormone responses to hypoglycemia in normal and diabetic humans.

Authors:  S A Amiel; D C Simonson; W V Tamborlane; R A DeFronzo; R S Sherwin
Journal:  Diabetes       Date:  1987-04       Impact factor: 9.461

4.  Effect of jejunoileal bypass operation and Billroth II resection on postprandial plasma pancreatic polypeptide release.

Authors:  R Jorde; P G Burhol
Journal:  Scand J Gastroenterol       Date:  1982-08       Impact factor: 2.423

5.  Hierarchy of glycemic thresholds for counterregulatory hormone secretion, symptoms, and cerebral dysfunction.

Authors:  A Mitrakou; C Ryan; T Veneman; M Mokan; T Jenssen; I Kiss; J Durrant; P Cryer; J Gerich
Journal:  Am J Physiol       Date:  1991-01

6.  Effect of intensive insulin therapy on glycemic thresholds for counterregulatory hormone release.

Authors:  S A Amiel; R S Sherwin; D C Simonson; W V Tamborlane
Journal:  Diabetes       Date:  1988-07       Impact factor: 9.461

7.  Catecholamine binding and concentrations in acute phase plasma after surgery.

Authors:  G Sager; T Trovik; L Slørdal; R Jaeger; P S Prytz; J Brox; O Reikerås
Journal:  Scand J Clin Lab Invest       Date:  1988-09       Impact factor: 1.713

8.  Counterregulatory hormonal responses to hypoglycaemia in type 1 (insulin-dependent) diabetes: evidence for diminished hypothalamic-pituitary hormonal secretion.

Authors:  B M Frier; B M Fisher; C E Gray; G H Beastall
Journal:  Diabetologia       Date:  1988-07       Impact factor: 10.122

9.  Modest decrements in plasma glucose concentration cause early impairment in cognitive function and later activation of glucose counterregulation in the absence of hypoglycemic symptoms in normal man.

Authors:  P De Feo; V Gallai; G Mazzotta; G Crispino; E Torlone; G Perriello; M M Ventura; F Santeusanio; P Brunetti; G B Bolli
Journal:  J Clin Invest       Date:  1988-08       Impact factor: 14.808

10.  Reduced neuroendocrine and symptomatic responses to subsequent hypoglycemia after 1 episode of hypoglycemia in nondiabetic humans.

Authors:  S R Heller; P E Cryer
Journal:  Diabetes       Date:  1991-02       Impact factor: 9.461

View more
  7 in total

1.  Defining hypoglycaemia: what level has clinical relevance?

Authors:  B M Frier
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

2.  Preventing hypoglycaemia: what is the appropriate glucose alert value?

Authors:  P E Cryer
Journal:  Diabetologia       Date:  2008-11-19       Impact factor: 10.122

3.  Increased insulin sensitivity and basal insulin effectiveness in postprandial reactive hypoglycaemia.

Authors:  J F Brun; O Bouix; J F Monnier; C Blachon; N Jourdan; M T Baccara; C Fédou; A Orsetti
Journal:  Acta Diabetol       Date:  1996-03       Impact factor: 4.280

4.  Evaluation of a standardized hyperglucidic breakfast test in postprandial reactive hypoglycaemia.

Authors:  J F Brun; C Fédou; O Bouix; E Raynaud; A Orsetti
Journal:  Diabetologia       Date:  1995-04       Impact factor: 10.122

5.  Relative roles of insulin and hypoglycaemia on induction of neuroendocrine responses to, symptoms of, and deterioration of cognitive function in hypoglycaemia in male and female humans.

Authors:  C Fanelli; S Pampanelli; L Epifano; A M Rambotti; M Ciofetta; F Modarelli; A Di Vincenzo; B Annibale; M Lepore; C Lalli
Journal:  Diabetologia       Date:  1994-08       Impact factor: 10.122

6.  The nature of the control of blood glucose in those with poorer glucose tolerance influences mood and cognition.

Authors:  Hayley Young; David Benton
Journal:  Metab Brain Dis       Date:  2014-03-26       Impact factor: 3.584

Review 7.  Glycaemic thresholds for counterregulatory hormone and symptom responses to hypoglycaemia in people with and without type 1 diabetes: a systematic review.

Authors:  Clementine E M Verhulst; Therese W Fabricius; Steven Teerenstra; Peter L Kristensen; Cees J Tack; Rory J McCrimmon; Simon Heller; Mark L Evans; Stephanie A Amiel; Ulrik Pedersen-Bjergaard; Bastiaan E de Galan
Journal:  Diabetologia       Date:  2022-07-22       Impact factor: 10.460

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.